Author(s): Ayalew S, Confer AW, Shrestha B, Wilson AE, Montelongo M
Abstract Share this page
Abstract Mannheimia haemolytica, a major causative agent in bovine respiratory disease, inflicts extensive losses each year on cattle producers. Commercially available vaccines are only partially efficacious. Immunity to M. haemolytica requires antibodies to secreted toxins and outer membrane proteins (OMPs) of the bacterium. Gram-negative bacteria produce membrane blebs or vesicles, the membrane components of which are primarily derived from OMPs. Accordingly, vesicles have been used as immunogens with various degrees of success. This study characterized components of M. haemolytica vesicles and determined their immunogenicity in mice and cattle. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of vesicles from this bacterium identified 226 proteins, of which 58 (25.6\%) were OMPs and periplasmic and one (0.44\%) was extracellular. Vesicles were used to vaccinate dairy calves and BALB/c mice. Analyses of sera from calves and mice by enzyme-linked immunosorbent assay (ELISA) showed that circulating antibodies against M. haemolytica whole cells and leukotoxin were significantly higher on days 21 and 28 (P < 0.05) than on day 0. For control calves and mice, there were no significant differences in serum anti-whole-cell and leukotoxin antibody levels from days 0 and 21 or 28, respectively. Lesion scores of lungs from vaccinated calves (15.95\%) were significantly (P < 0.05) lower than those from nonvaccinated calves (42.65\%). Sera from mice on day 28 and calves on day 21 showed 100\% serum bactericidal activity. Sera from vesicle-vaccinated mice neutralized leukotoxin.
This article was published in Clin Vaccine Immunol
and referenced in Journal of Vaccines & Vaccination